Pionyr Immunotherapeutics

0 followers


Pionyr Immunotherapeutics discovers and develops first-in-class biologic drugs that fine-tune natural immune responses to increase immune defenses for diseases such as cancer, or to dampen immune responses in autoimmune diseases.

Org chart

Steven P. James
President & CEO

Steven P. James

Collapse
Evan Greger
SVP & CTO
Davide Edghill
Senior Director, Data Management
Kristen Pierce
VP, Translational Medicine
Linda Liang
VP, Protein Sciences
Marc Chamberlain
Senior Medical Director
Isabel Luther
Senior Director, Clinical Operations
Yunfeng Li
Senior Director, Biostatistics
Chidi Obi
Associate Director, Analytical Development And Quality Control